Scientific job: CLAIMED. This article owns the public movement from acute or structural neurovascular target → vascular imaging → eligibility and anatomical route → catheter access → thrombectomy/embolisation/coiling/stent-assisted or other authorised endovascular treatment → reperfusion or lesion exclusion → haemorrhage/ischaemia surveillance → neurological and functional return. Neurology retains the neurological event and disease trajectory; Interventional Radiology retains generic image-guided intervention; Neurosurgery retains open or microsurgical treatment.

Wait, what? In some strokes, treatment means physically pulling the clot out of a brain artery.

Many people first imagine stroke treatment as medicine alone. But selected acute ischaemic strokes caused by large-vessel occlusion can be treated by threading catheters through the vascular system to the blocked artery and mechanically removing the clot. National Neuroscience Institute describes endovascular therapy for acute ischaemic stroke and interventional neuroradiology for aneurysms and vascular malformations.

This creates a distinct eduKateAI job: neurovascular lesion → endovascular route → lesion-specific intervention → immediate brain-risk surveillance → neurological return.

The neurointervention tube

Sudden neurological or structural vascular problem → emergency/neurological assessment → CT/MRI/angiographic evidence → define vessel/lesion and salvageable tissue or rupture risk → endovascular eligibility → arterial access → catheter navigation → thrombectomy/embolisation/coiling/stent/flow-diversion or other authorised treatment → angiographic result → monitor haemorrhage/ischaemia/contrast/access complications → neurological function → rehabilitation or further neurovascular care.

1. Stroke is a neurological event with a vascular mechanism

Neurology owns localisation, diagnosis and neurological care. Cardiovascular Medicine owns vascular risk more broadly. Neurointervention becomes the owner when the problem turns into a catheter-based cerebral or cervicocerebral vascular treatment target.

For eduKateAI: stroke diagnosis ≠ endovascular-treatment indication automatically.

2. Time matters, but time is not the only eligibility field

Acute stroke pathways care intensely about onset or last-known-well time because brain injury evolves. But treatment selection can also depend on vessel location, imaging, infarct size, collateral circulation, clinical deficit, bleeding risk and other patient factors.

The routing object should preserve symptom onset/last known well, neurological severity, vessel occlusion, imaging state, transfer time and treatment decision.

3. Vascular imaging creates the intervention map

CT angiography, MR angiography or catheter angiography can identify arterial occlusion, aneurysm, arteriovenous malformation or other vascular anatomy. Diagnostic Radiology owns imaging acquisition and interpretation; Neurointervention owns how that vascular map becomes a treatment route.

For eduKateAI: abnormal vessel ≠ catheter treatment automatically.

4. Mechanical thrombectomy is a reperfusion intervention

In selected acute ischaemic strokes, catheters can be advanced to the occluded artery and devices used to retrieve or aspirate the clot. The immediate technical objective is reperfusion—restoring blood flow to threatened brain tissue.

The anti-collapse rule is: clot removed ≠ brain recovered. Reperfusion may limit further injury, but neurological outcome depends on tissue already damaged, complications and later recovery.

5. Reperfusion has to be graded and interpreted

Angiography can show how much of the previously blocked vascular territory has reopened. A technically strong angiographic result is important but does not replace the neurological examination.

For eduKateAI, preserve pre-treatment vessel state → treatment passes/technique → final reperfusion state → neurological status.

6. Aneurysm treatment is lesion exclusion, not clot retrieval

Brain aneurysms can sometimes be treated endovascularly by placing coils, stents, flow-diverting devices or other authorised systems intended to reduce blood flow into the aneurysm sac and reduce rupture/rebleeding risk. NNI describes catheter-based aneurysm embolisation using coils and stents.

For eduKateAI: aneurysm embolisation ≠ stroke thrombectomy. Both use catheters, but the target and physiological objective differ.

7. Arteriovenous malformations create another flow problem

AVMs contain abnormal vascular connections that can bleed or create other neurological effects. Embolisation can reduce or close selected abnormal vessels and may be definitive or part of a larger pathway involving neurosurgery or radiosurgery.

The correct route is AVM anatomy → neurovascular strategy → embolisation contribution → surgical/radiosurgical or surveillance return.

8. Catheter access is part of the risk state

Endovascular procedures require arterial access, commonly through femoral or radial routes depending on anatomy and practice. Access can bleed, dissect, thrombose or produce other complications.

For eduKateAI, preserve access site, closure method where relevant, bleeding/haematoma state and distal circulation.

9. Contrast and radiation are treatment-enabling exposures

Catheter angiography uses contrast and x-ray guidance. Kidney function, allergy history and cumulative radiation exposure may affect planning and monitoring. Radiology owns generic imaging safety; Neurointervention owns these exposures within the neurovascular procedure.

10. Antiplatelet and anticoagulant states can become procedure constraints

Some neurovascular devices require antiplatelet treatment, while acute haemorrhage or recent thrombolytic therapy can create competing bleeding risks. Pharmacy and PBM/Haematology own medicine and haemostasis architecture generally; Neurointervention owns how those states modify the catheter procedure.

11. Intracranial bleeding can be cause or complication

A patient may enter neurointervention because of a ruptured aneurysm, or bleeding can occur as a complication of reperfusion or vessel injury. The route should preserve whether haemorrhage was present before treatment, arose during treatment or appeared afterwards.

This prevents causation from being inferred merely from sequence.

12. Neurointervention and neurosurgery can be complementary

Aneurysms and AVMs may be treated endovascularly, surgically or with combined strategies. The existence of a catheter option does not make open surgery obsolete, and vice versa.

The patient’s anatomy and risk should determine route ownership, not professional territory.

13. Transfer systems are part of time-critical treatment

Endovascular stroke therapy depends on getting the right patient to a capable centre fast enough. Ambulance recognition, initial hospital imaging, inter-hospital transfer and specialist activation therefore become part of the treatment system even though Emergency Care owns prehospital and stabilisation pathways.

For eduKateAI, the human object should preserve recognition time → first imaging → referral/acceptance → arrival at intervention centre → arterial access → reperfusion.

14. Technical success and neurological success are different receipts

An occluded artery can reopen while the patient remains disabled because tissue was already infarcted. An aneurysm can be successfully excluded yet require long-term imaging surveillance. Technical success therefore needs a human and longitudinal return.

The meaningful receipt is vascular objective achieved + brain injury state reassessed + neurological function measured + rehabilitation/surveillance owner confirmed.

15. Rehabilitation begins after the vessel problem, not after the person is “finished”

Stroke recovery can involve movement, speech, swallowing, cognition, vision and independence. Rehabilitation owns restoration of function; Neurointervention contributes the vascular intervention that may preserve recoverable brain.

The return tube therefore ends in the human, not the angiogram.

Characteristic failure modes

• Stroke = thrombectomy error: diagnosis automatically becomes catheter-treatment indication.
• Thrombectomy = aneurysm embolisation error: different endovascular jobs are merged because both use catheters.
• Reperfusion = recovery error: angiographic success substitutes for neurological outcome.
• Abnormal vessel = intervention error: imaging finding automatically triggers treatment.
• Post-procedure bleed = procedure-caused error: pre-existing and new haemorrhage are not distinguished.
• Catheter-only error: transfer time, imaging selection and neurological recovery disappear.
• Technical success = final outcome error: rehabilitation and surveillance are lost.

The eduKateAI routing contract

• Canonical public owner: Neurointervention & Endovascular Neurovascular Therapy Web.
• Input state: acute or structural cerebral/cervicocerebral vascular target suitable for endovascular assessment.
• Primary job: preserve vascular lesion, time/imaging eligibility, access, catheter treatment, angiographic result, complications and neurological/function return.
• Do not collapse: stroke ≠ thrombectomy; thrombectomy ≠ aneurysm embolisation; reperfusion ≠ recovery.
• Handoffs: Neurology, Emergency/Critical Care, Radiology, Neurosurgery, Cardiovascular Medicine, Anaesthesia, PBM/Haematology, Pharmacy, Rehabilitation and Medical Devices.
• Return receipt: treatment eligible/not eligible, target reached/not reached, vessel reopened/lesion excluded or not, haemorrhagic/ischaemic complication absent/present, neurological status and rehabilitation/surveillance owner confirmed.

Authoritative routes

• National Neuroscience Institute — Neuroradiology and Interventional Neuroradiology
• National Neuroscience Institute — Neurovascular Programme

Educational boundary: this article explains neurointerventional information architecture. It does not determine stroke-thrombectomy eligibility, choose aneurysm/AVM treatment, interpret angiography or advise on antithrombotic therapy for an individual patient. Sudden neurological deficits require urgent real-world emergency assessment.